These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension. McClellan KJ; Wiseman LR; Wilde MI Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688 [TBL] [Abstract][Full Text] [Related]
7. Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients? Cruz DN; Mahnensmith RL; Perazella MA Am J Kidney Dis; 1997 Dec; 30(6):772-9. PubMed ID: 9398120 [TBL] [Abstract][Full Text] [Related]
8. Treatment of orthostatic hypotension with octreotide. Hoeldtke RD; Israel BC J Clin Endocrinol Metab; 1989 Jun; 68(6):1051-9. PubMed ID: 2723026 [TBL] [Abstract][Full Text] [Related]
9. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997 [TBL] [Abstract][Full Text] [Related]
10. Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine. Hoeldtke RD; Bryner KD; Hoeldtke ME; Hobbs G Clin Auton Res; 2006 Dec; 16(6):390-5. PubMed ID: 17036177 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131 [TBL] [Abstract][Full Text] [Related]
12. Midodrine for orthostatic hypotension. Med Lett Drugs Ther; 1997 Jun; 39(1003):59-60. PubMed ID: 9205432 [No Abstract] [Full Text] [Related]
13. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child. Olgar S; Omeroglu RE Pediatr Cardiol; 2007; 28(4):309-10. PubMed ID: 17530320 [TBL] [Abstract][Full Text] [Related]
14. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension. Cruz DN Expert Opin Pharmacother; 2000 May; 1(4):835-40. PubMed ID: 11249519 [TBL] [Abstract][Full Text] [Related]
15. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study. Smith W; Wan H; Much D; Robinson AG; Martin P Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462 [TBL] [Abstract][Full Text] [Related]
17. The Treatment of Primary Orthostatic Hypotension. Hale GM; Valdes J; Brenner M Ann Pharmacother; 2017 May; 51(5):417-428. PubMed ID: 28092986 [TBL] [Abstract][Full Text] [Related]
18. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Jankovic J; Gilden JL; Hiner BC; Kaufmann H; Brown DC; Coghlan CH; Rubin M; Fouad-Tarazi FM Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093 [TBL] [Abstract][Full Text] [Related]
19. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. Schrage WG; Eisenach JH; Dinenno FA; Roberts SK; Johnson CP; Sandroni P; Low PA; Joyner MJ J Appl Physiol (1985); 2004 Nov; 97(5):1978-84. PubMed ID: 15273244 [TBL] [Abstract][Full Text] [Related]
20. Midodrine in neurogenic orthostatic hypotension. A new treatment. Gilden JL Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]